Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001104659-18-024689
Filing Date
2018-04-18
Accepted
2018-04-18 06:58:04
Documents
7
Effectiveness Date
2018-04-18

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT FILED SOLELY TO ADD EXHIBITS a18-9972_1posex.htm POS EX 76582
2 EX-99.B(A)(XIV) a18-9972_1ex99dbaxiv.htm EX-99.B(A)(XIV) 18304
3 EX-99.B(B) a18-9972_1ex99dbb.htm EX-99.B(B) 84240
4 EX-99.B(K)(VI) a18-9972_1ex99dbkvi.htm EX-99.B(K)(VI) 25624
5 EX-99.B(N)(II) a18-9972_1ex99dbnii.htm EX-99.B(N)(II) 4601
7 GRAPHIC g99721cai001.gif GRAPHIC 2687
8 GRAPHIC g99721mii001.jpg GRAPHIC 2208
  Complete submission text file 0001104659-18-024689.txt   217428
Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 6177728515
TEKLA LIFE SCIENCES INVESTORS (Filer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: POS EX | Act: 33 | File No.: 333-195326 | Film No.: 18760204